Ardent Health Partners, LLC (NYSE:ARDT - Get Free Report) has received a consensus rating of "Buy" from the eleven ratings firms that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation, nine have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price target among brokers that have covered the stock in the last year is $21.70.
ARDT has been the topic of a number of research reports. Citigroup assumed coverage on shares of Ardent Health Partners in a report on Monday, August 12th. They set a "buy" rating and a $21.00 target price on the stock. Stephens started coverage on Ardent Health Partners in a report on Monday, August 12th. They set an "overweight" rating and a $24.00 price target on the stock. Truist Financial began coverage on Ardent Health Partners in a research report on Monday, August 12th. They issued a "buy" rating and a $21.00 price target on the stock. Leerink Partners began coverage on shares of Ardent Health Partners in a research note on Monday, August 12th. They set an "outperform" rating and a $23.00 target price on the stock. Finally, Royal Bank of Canada initiated coverage on shares of Ardent Health Partners in a report on Monday, August 12th. They issued an "outperform" rating and a $23.00 target price on the stock.
Get Our Latest Analysis on ARDT
Ardent Health Partners Stock Performance
NYSE:ARDT traded down $0.39 during trading hours on Friday, reaching $19.19. 286,573 shares of the stock were exchanged, compared to its average volume of 389,542. Ardent Health Partners has a twelve month low of $15.00 and a twelve month high of $20.30.
Ardent Health Partners (NYSE:ARDT - Get Free Report) last announced its earnings results on Wednesday, August 14th. The company reported $0.35 EPS for the quarter, beating analysts' consensus estimates of $0.30 by $0.05. The firm had revenue of $1.47 billion for the quarter, compared to analysts' expectations of $1.46 billion. Equities research analysts predict that Ardent Health Partners will post 1.21 EPS for the current fiscal year.
Ardent Health Partners Company Profile
(
Get Free ReportWe are the fourth largest privately held, for-profit operator of hospitals and a leading provider of healthcare services in the United States(1). We currently operate in eight growing mid-sized urban markets across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. We deliver care through a system of 30 acute care hospitals, more than 200 sites of care, and over 1,700 providers that are either employed by or affiliated with us(2), as of March 31, 2024.
Featured Articles
Before you consider Ardent Health Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health Partners wasn't on the list.
While Ardent Health Partners currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.